Home › with Excess of Blasts Refractory Anemia › Ohio › Columbus
with Excess of Blasts Refractory Anemia clinical trials in Columbus, OH
3 studies for with Excess of Blasts Refractory Anemia are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Luspatercept + Darbepoetin in MDS
RecruitingPhase 2Healthy volunteers welcome
- The Ohio State University - The James Cancer Hospital and Solove Research Institute: Comprehensive Cancer Center (, Columbus
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
RecruitingPhase 2
- Ohio State University Comprehensive Cancer Center, Columbus
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
RecruitingPhase 2/3
- Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
with Excess of Blasts Refractory Anemia trials in other cities
- Houston, TX6 studies
- Seattle, WA5 studies
- New York City, NY3 studies
- Boston, MA3 studies
- Washington, DC3 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer57 studies
- Breast Cancer40 studies
- Ovarian Cancer39 studies
- Cancer (all types)38 studies
- Lung Cancer37 studies
- Acute Myeloid Leukemia35 studies
- Chronic Lymphocytic Leukemia28 studies
- Metastatic Cancer27 studies
- Endometrial Cancer25 studies
- Prostate Cancer24 studies
- Multiple Myeloma24 studies
- Colorectal Cancer24 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.